EFCAB8
gene geneOn this page
Summary
EFCAB8 (EF-hand calcium binding domain 8, HGNC:34532) is a protein-coding gene on chromosome 20q11.21, encoding EF-hand calcium-binding domain-containing protein 8 (A8MWE9).
Predicted to enable calcium ion binding activity.
Source: NCBI Gene 388795 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 3 total — 1 pathogenic
- MANE Select transcript:
NM_001143967
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34532 |
| Approved symbol | EFCAB8 |
| Name | EF-hand calcium binding domain 8 |
| Location | 20q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000215529 |
| Ensembl biotype | protein_coding |
| Entrez | 388795 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 retained_intron
ENST00000400522, ENST00000524882, ENST00000533479, ENST00000618684
RefSeq mRNA: 1 — MANE Select: NM_001143967
NM_001143967
Canonical transcript exons
ENST00000400522 — 27 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001543319 | 32878704 | 32878807 |
| ENSE00001543320 | 32875926 | 32876044 |
| ENSE00001543321 | 32867582 | 32867747 |
| ENSE00001556082 | 32889301 | 32889406 |
| ENSE00001647096 | 32912794 | 32912864 |
| ENSE00001657025 | 32920078 | 32920215 |
| ENSE00001664452 | 32961136 | 32961845 |
| ENSE00001672924 | 32863783 | 32863834 |
| ENSE00001691115 | 32930398 | 32930616 |
| ENSE00001694327 | 32906843 | 32906994 |
| ENSE00001728712 | 32911480 | 32911707 |
| ENSE00001743557 | 32858923 | 32859006 |
| ENSE00001751758 | 32906562 | 32906629 |
| ENSE00001759410 | 32931178 | 32931336 |
| ENSE00001763787 | 32898493 | 32898623 |
| ENSE00001768489 | 32917301 | 32917505 |
| ENSE00001775463 | 32896454 | 32896527 |
| ENSE00001781039 | 32960063 | 32960161 |
| ENSE00001784469 | 32959778 | 32959982 |
| ENSE00001799883 | 32893174 | 32893298 |
| ENSE00003173430 | 32885505 | 32885640 |
| ENSE00003208410 | 32892213 | 32892297 |
| ENSE00003569932 | 32918362 | 32918574 |
| ENSE00003756413 | 32958421 | 32958550 |
| ENSE00003757171 | 32909821 | 32909931 |
| ENSE00003757404 | 32943636 | 32943804 |
| ENSE00003758303 | 32908275 | 32908412 |
Expression profiles
Bgee: expression breadth broad, 100 present calls, max score 77.42.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.52 | gold quality |
| sural nerve | UBERON:0015488 | 67.49 | silver quality |
| left testis | UBERON:0004533 | 67.20 | gold quality |
| right testis | UBERON:0004534 | 66.79 | gold quality |
| testis | UBERON:0000473 | 66.56 | gold quality |
| blood | UBERON:0000178 | 65.09 | gold quality |
| granulocyte | CL:0000094 | 63.48 | gold quality |
| vermiform appendix | UBERON:0001154 | 52.63 | gold quality |
| spleen | UBERON:0002106 | 52.18 | gold quality |
| monocyte | CL:0000576 | 50.64 | gold quality |
| mucosa of stomach | UBERON:0001199 | 50.41 | gold quality |
| lymph node | UBERON:0000029 | 50.34 | gold quality |
| leukocyte | CL:0000738 | 50.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 49.36 | gold quality |
| pituitary gland | UBERON:0000007 | 48.99 | gold quality |
| bone marrow | UBERON:0002371 | 48.60 | gold quality |
| tonsil | UBERON:0002372 | 48.58 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 47.84 | gold quality |
| small intestine | UBERON:0002108 | 47.77 | gold quality |
| gall bladder | UBERON:0002110 | 47.38 | gold quality |
| left uterine tube | UBERON:0001303 | 47.37 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 47.03 | gold quality |
| duodenum | UBERON:0002114 | 46.95 | silver quality |
| gastrocnemius | UBERON:0001388 | 46.23 | gold quality |
| urinary bladder | UBERON:0001255 | 46.18 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 46.09 | gold quality |
| left coronary artery | UBERON:0001626 | 45.83 | gold quality |
| islet of Langerhans | UBERON:0000006 | 45.55 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 45.52 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.52 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Efcab8 | ENSMUSG00000044083 |
| rattus_norvegicus | Efcab8 | ENSRNOG00000070431 |
| caenorhabditis_elegans | WBGENE00004767 |
Paralogs (14): WDR54 (ENSG00000005448), FBXW11 (ENSG00000072803), FBXW7 (ENSG00000109670), TRAF7 (ENSG00000131653), FBXW9 (ENSG00000132004), FBXO36 (ENSG00000153832), WDR64 (ENSG00000162843), FBXW12 (ENSG00000164049), BTRC (ENSG00000166167), WDR49 (ENSG00000174776), FBXW8 (ENSG00000174989), PAAF1 (ENSG00000175575), WDR86 (ENSG00000187260), FBXO16 (ENSG00000214050)
Protein
Protein identifiers
EF-hand calcium-binding domain-containing protein 8 — A8MWE9 (reviewed: A8MWE9)
All UniProt accessions (2): A0A096LNH2, A8MWE9
RefSeq proteins (1): NP_001137439* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR051242 | WD-EF-hand_domain | Family |
UniProt features (3 total): domain 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MWE9-F1 | 69.52 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 13 (showing top):
chr20q11, CBX5_TARGET_GENES, HMGA1_TARGET_GENES, ZNF707_TARGET_GENES, DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS, DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS, DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS, ZSCAN5DP_TARGET_GENES, GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN, GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP, GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP, GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN, GOMF_CALCIUM_ION_BINDING
GO Biological Process (0):
GO Molecular Function (2): calcium ion binding (GO:0005509), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
358 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EFCAB8 | TEX13D | A0A0J9YY54 | 506 |
| EFCAB8 | A0A2R8Y455 | A0A2R8Y455 | 495 |
| EFCAB8 | BPIFB2 | Q8N4F0 | 473 |
| EFCAB8 | COMMD7 | Q86VX2 | 469 |
| EFCAB8 | MTRNR2L3 | P0CJ70 | 468 |
| EFCAB8 | POP1 | Q99575 | 463 |
| EFCAB8 | WDR49 | Q8IV35 | 460 |
| EFCAB8 | SUN5 | Q8TC36 | 458 |
| EFCAB8 | TEKTL1 | Q8IYK2 | 439 |
| EFCAB8 | C5orf15 | Q8NC54 | 434 |
| EFCAB8 | OR5H2 | Q8NGV7 | 431 |
| EFCAB8 | TLCD1 | Q96CP7 | 428 |
| EFCAB8 | VSTM2L | Q96N03 | 398 |
| EFCAB8 | CDHR4 | A6H8M9 | 397 |
| EFCAB8 | ZNF17 | P17021 | 396 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2AHC3, A4FU69, A5WUN7, A7E379, A8MWE9, D3Z6S9, D3Z8E6, D3ZSP7, D4AEC2, O43149, O88196, P53804, Q06190, Q06BI3, Q08AD1, Q12923, Q13009, Q13129, Q3UMB5, Q4R8X0, Q5RBH9, Q5SSH7, Q5SW75, Q5T5Y3, Q60610, Q66HC0, Q6DGK9, Q6IRN6, Q6NZK8, Q76I76, Q80VH0, Q80X60, Q86WZ0, Q8C115, Q8C1B1, Q8C9R9, Q8CDN1, Q8ND61, Q8WWI1, Q99J45
Diamond homologs: A8MWE9, Q8C9R9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1457888 | NC_000020.10:g.(?31189994)(34287210_?)del | Pathogenic |
SpliceAI
5457 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:32875921:T:TA | acceptor_gain | 1.0000 |
| 20:32875921:TGAA:T | acceptor_loss | 1.0000 |
| 20:32875922:GAAG:G | acceptor_loss | 1.0000 |
| 20:32875923:AAGCC:A | acceptor_loss | 1.0000 |
| 20:32875924:A:AG | acceptor_gain | 1.0000 |
| 20:32875924:A:T | acceptor_loss | 1.0000 |
| 20:32875925:G:GG | acceptor_gain | 1.0000 |
| 20:32875925:G:GT | acceptor_loss | 1.0000 |
| 20:32877815:GGGCC:G | donor_gain | 1.0000 |
| 20:32878808:G:GG | donor_gain | 1.0000 |
| 20:32885639:GG:G | donor_gain | 1.0000 |
| 20:32885640:GG:G | donor_gain | 1.0000 |
| 20:32893253:A:AG | donor_gain | 1.0000 |
| 20:32893254:G:GG | donor_gain | 1.0000 |
| 20:32898623:GGT:G | donor_loss | 1.0000 |
| 20:32898624:G:GA | donor_loss | 1.0000 |
| 20:32898625:T:A | donor_loss | 1.0000 |
| 20:32907036:G:T | donor_gain | 1.0000 |
| 20:32908269:CCCCA:C | acceptor_loss | 1.0000 |
| 20:32908271:CCAGA:C | acceptor_loss | 1.0000 |
| 20:32908272:CAG:C | acceptor_loss | 1.0000 |
| 20:32908273:A:AC | acceptor_loss | 1.0000 |
| 20:32908273:A:AG | acceptor_gain | 1.0000 |
| 20:32908274:G:GT | acceptor_gain | 1.0000 |
| 20:32908274:GA:G | acceptor_gain | 1.0000 |
| 20:32908274:GAAT:G | acceptor_gain | 1.0000 |
| 20:32908410:TCA:T | donor_gain | 1.0000 |
| 20:32908413:G:GG | donor_gain | 1.0000 |
| 20:32917501:AGAGG:A | donor_gain | 1.0000 |
| 20:32917502:GAGG:G | donor_gain | 1.0000 |
AlphaMissense
8550 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:32875943:T:C | F76L | 0.978 |
| 20:32875945:C:A | F76L | 0.978 |
| 20:32875945:C:G | F76L | 0.978 |
| 20:32876003:T:C | F96L | 0.970 |
| 20:32876005:T:A | F96L | 0.970 |
| 20:32876005:T:G | F96L | 0.970 |
| 20:32875944:T:C | F76S | 0.958 |
| 20:32876037:T:A | V107D | 0.954 |
| 20:32878734:T:C | F120L | 0.951 |
| 20:32878736:C:A | F120L | 0.951 |
| 20:32878736:C:G | F120L | 0.951 |
| 20:32876004:T:C | F96S | 0.940 |
| 20:32867720:T:C | F61L | 0.938 |
| 20:32867722:T:A | F61L | 0.938 |
| 20:32867722:T:G | F61L | 0.938 |
| 20:32876001:T:C | L95P | 0.938 |
| 20:32876044:G:C | W109C | 0.936 |
| 20:32876044:G:T | W109C | 0.936 |
| 20:32876042:T:A | W109R | 0.934 |
| 20:32876042:T:C | W109R | 0.934 |
| 20:32876011:G:C | K98N | 0.911 |
| 20:32876011:G:T | K98N | 0.911 |
| 20:32876017:C:A | D100E | 0.904 |
| 20:32876017:C:G | D100E | 0.904 |
| 20:32878710:T:G | Y112D | 0.898 |
| 20:32875992:T:C | L92P | 0.893 |
| 20:32876004:T:G | F96C | 0.884 |
| 20:32867721:T:G | F61C | 0.868 |
| 20:32875944:T:G | F76C | 0.862 |
| 20:32876015:G:C | D100H | 0.855 |
dbSNP variants (sampled 300 via entrez): RS1000007475 (20:32900891 A>G,T), RS1000022421 (20:32949377 C>G), RS1000027549 (20:32925706 G>C), RS1000038437 (20:32949869 G>A), RS1000064053 (20:32904836 A>G), RS1000065205 (20:32909869 A>C,G), RS1000101466 (20:32866565 G>T), RS1000116044 (20:32913232 A>G,T), RS1000132821 (20:32866283 G>C), RS1000155448 (20:32959280 C>T), RS1000218012 (20:32889809 C>G), RS1000249129 (20:32889959 C>T), RS1000256421 (20:32871831 C>A), RS1000265387 (20:32912838 A>G,T), RS1000278959 (20:32928574 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008152_169 | Weight | 7.000000e-06 |
| GCST010703_192 | Brain morphology (MOSTest) | 8.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004338 | body weight |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| resorcinol | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.